Literature DB >> 34233030

Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD.

Sílvia Vilarinho1, Veeral Ajmera2, Melanie Zheng1, Rohit Loomba2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34233030      PMCID： PMC8463418          DOI： 10.1002/hep.32047

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.298


× No keyword cloud information.
  81 in total

1.  Epidemiology of chronic liver diseases in the USA in the past three decades.

Authors:  Zobair M Younossi; Maria Stepanova; Youssef Younossi; Pegah Golabi; Alita Mishra; Nila Rafiq; Linda Henry
Journal:  Gut       Date:  2019-07-31       Impact factor: 23.059

2.  The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.

Authors:  Anna Carter; Simon Mark Brackley; Jiali Gao; Jake Peter Mann
Journal:  J Hepatol       Date:  2018-10-11       Impact factor: 25.083

Review 3.  Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond.

Authors:  Marcin Krawczyk; Roman Liebe; Frank Lammert
Journal:  Gastroenterology       Date:  2020-02-15       Impact factor: 22.682

4.  Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers.

Authors:  Marcin Krawczyk; Heike Bantel; Monika Rau; Jörn M Schattenberg; Frank Grünhage; Anita Pathil; Münevver Demir; Johannes Kluwe; Tobias Boettler; Susanne N Weber; Andreas Geier; Frank Lammert
Journal:  J Hum Genet       Date:  2018-02-26       Impact factor: 3.172

5.  Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.

Authors:  M A Banerji; N Faridi; R Atluri; R L Chaiken; H E Lebovitz
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

Review 6.  Update on NAFLD genetics: From new variants to the clinic.

Authors:  Eric Trépo; Luca Valenti
Journal:  J Hepatol       Date:  2020-03-04       Impact factor: 25.083

7.  Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction Study.

Authors:  Connor A Emdin; Mary Haas; Veeral Ajmera; Tracey G Simon; Julian Homburger; Cynthia Neben; Lan Jiang; Wei-Qi Wei; Qiping Feng; Alicia Zhou; Joshua Denny; Kathleen Corey; Rohit Loomba; Sekar Kathiresan; Amit V Khera
Journal:  Gastroenterology       Date:  2020-12-11       Impact factor: 22.682

8.  Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation.

Authors:  Cynthia M Valerio; Lenita Zajdenverg; José Egídio P de Oliveira; Patricia B Mory; Regina S Moyses; Amélio F Godoy-Matos
Journal:  Diabetol Metab Syndr       Date:  2012-08-31       Impact factor: 3.320

9.  Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease.

Authors:  Nandini M Meyersohn; Thomas Mayrhofer; Kathleen E Corey; Daniel O Bittner; Pedro V Staziaki; Balint Szilveszter; Travis Hallett; Michael T Lu; Stefan B Puchner; Tracey G Simon; Borek Foldyna; Deepak Voora; Geoffrey S Ginsburg; Pamela S Douglas; Udo Hoffmann; Maros Ferencik
Journal:  Clin Gastroenterol Hepatol       Date:  2020-07-21       Impact factor: 13.576

Review 10.  Familial Partial Lipodystrophy (FPLD): Recent Insights.

Authors:  Christos Bagias; Angeliki Xiarchou; Alexandra Bargiota; Stelios Tigas
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-06       Impact factor: 3.168
View more
  3 in total

1.  Identification of the Non-Alcoholic Fatty Liver Disease Molecular Subtypes Associated With Clinical and Immunological Features via Bioinformatics Methods.

Authors:  Ziyu Liu; Yufei Li; Caihong Yu
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

2.  Association between the atherogenic index of plasma and new-onset non-alcoholic fatty liver disease in non-obese participants.

Authors:  Kemin Li; Ji Li; Xiaoyun Cheng; Jing Wang; Jingnan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

3.  Nonalcoholic fatty liver disease in relation to the remission and progression along the glycemic continuum.

Authors:  Zhuojun Xin; Jiaojiao Huang; Qiuyu Cao; Jialu Wang; Ruixin He; Tianzhichao Hou; Yi Ding; Jieli Lu; Min Xu; Tiange Wang; Zhiyun Zhao; Weiqing Wang; Guang Ning; Yufang Bi; Yu Xu; Mian Li
Journal:  J Diabetes       Date:  2022-09       Impact factor: 4.530
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.